Today in Medicine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.

Press releases published on September 30, 2026

7 hours ago

OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution

Indeterminate GlobeNewswire

7 hours ago

Silo Pharma’s QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility

Indeterminate GlobeNewswire

Sep. 30, 2026

Pet Longevity Supplement Market Report Analyzes Market Trends, Segment Details, and Business Approaches

Indeterminate EIN Presswire

7 hours ago

Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion

Indeterminate GlobeNewswire

7 hours ago

AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video

Indeterminate GlobeNewswire

7 hours ago

Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND

Indeterminate GlobeNewswire

7 hours ago

Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance

Indeterminate GlobeNewswire

7 hours ago

Candel Therapeutics Announces Integrated Clinical and Biomarker Data That Showed Durable Local and Systemic Immune Activation after Aglatimagene Besadenovec in Intermediate-Risk Localized Prostate Cancer

Indeterminate GlobeNewswire

7 hours ago

Project MEND Uses SteraMist to Safely Disinfect Medical Equipment for Reuse

Indeterminate GlobeNewswire

7 hours ago

Decoy Therapeutics to Present at The Small Cap Showcase

Indeterminate GlobeNewswire

7 hours ago

Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)

Indeterminate GlobeNewswire

Sep. 30, 2026

The Patient Digital Twin Platform Market is projected to grow at a CAGR of 34.5% by 2030

Indeterminate EIN Presswire

7 hours ago

Candel Therapeutics Announces New Data Showing Sustained Immune Remodeling More Than Two Years After Aglatimagene Besadenovec Treatment in Localized Prostate Cancer at ASTRO 2026

Indeterminate GlobeNewswire

7 hours ago

Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards

Indeterminate GlobeNewswire

Sep. 30, 2026

Brookdale Outlines Its Continuum of Care for National Recovery Month

Indeterminate EIN Presswire

7 hours ago

Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Indeterminate GlobeNewswire

7 hours ago

DiFusion Activates Operating Board to Scale Therapeutic Biomaterials Platform

Indeterminate GlobeNewswire

7 hours ago

Theriva™ Biologics Announces Publication of the Results from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer Published in Nature Medicine

Indeterminate GlobeNewswire

7 hours ago

Esperion Therapeutics Offers Short-Term Option for Diuretic Management Before Escalation to IV for Patients With Heart Failure

Indeterminate GlobeNewswire

7 hours ago

AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450

Indeterminate GlobeNewswire